Your browser doesn't support javascript.
loading
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.
Zhao, Peng; Ni, Ming; Ma, Dan; Fang, Qin; Zhang, Yan; Li, Yanju; Huang, Yi; Chen, Ying; Chai, Xiao; Zhan, Yun; Li, Yan; Kang, Qian; Zhao, Mei; Liu, Min; Zhang, Fengqi; Huang, Shisi; Wen, Shuangshuang; Deng, Bo; Wang, Jishi.
Afiliación
  • Zhao P; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
  • Ni M; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Ma D; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Fang Q; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Zhang Y; Department of Pharmacy, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Li Y; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Huang Y; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Chen Y; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
  • Chai X; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Zhan Y; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
  • Li Y; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Kang Q; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
  • Zhao M; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Liu M; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Zhang F; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Huang S; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
  • Wen S; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Deng B; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
  • Wang J; Guizhou Province Hematopoietic Stem Cell Transplantation Center, Key Laboratory of Hematological Disease Diagnostic & Treat Centre of Guizhou Province, Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
Ann Hematol ; 101(1): 119-130, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34568973
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Azacitidina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transfusión de Linfocitos / Compuestos Bicíclicos Heterocíclicos con Puentes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Azacitidina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transfusión de Linfocitos / Compuestos Bicíclicos Heterocíclicos con Puentes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article